151 related articles for article (PubMed ID: 21034775)
21. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia.
Gabrielli A; Zhang ZX; Cherubini G; Candela M; Savoldi S; Manzin A; Clementi M; Amoroso A; Sallberg M
Clin Exp Immunol; 1996 Jul; 105(1):59-64. PubMed ID: 8697636
[TBL] [Abstract][Full Text] [Related]
22. Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis C virus.
Tu B; Ziemann RN; Tieman BC; Hawksworth DJ; Tyner J; Scheffel J; Pinkus MS; Brophy SE; Werneke JM; Gutierrez R; White M
Clin Vaccine Immunol; 2010 Jun; 17(6):1040-7. PubMed ID: 20427624
[TBL] [Abstract][Full Text] [Related]
23. Immunodominant regions within the hepatitis C virus core and putative matrix proteins.
Sällberg M; Rudén U; Wahren B; Magnius LO
J Clin Microbiol; 1992 Aug; 30(8):1989-94. PubMed ID: 1380007
[TBL] [Abstract][Full Text] [Related]
24. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.
Löhr HF; Elste C; Dienes HP; Michel G; Braun HB; Meyer zum Büschenfelde KH; Gerken G
J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007
[TBL] [Abstract][Full Text] [Related]
25. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
26. Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma.
Jackson P; Petrik J; Alexander GJ; Pearson G; Allain JP
J Med Virol; 1997 Jan; 51(1):67-79. PubMed ID: 8986952
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.
Takao Y; Yamada A; Yutani S; Ono T; Nagao Y; Ando E; Ide T; Itoh K; Sata M
Med Microbiol Immunol; 2007 Sep; 196(3):157-64. PubMed ID: 17574493
[TBL] [Abstract][Full Text] [Related]
28. Significance of IgM anti-HCV core level in chronic hepatitis C.
Papatheodoridis GV; Delladetsima JK; Katsoulidou A; Sypsa V; Albrecht M; Michel G; Hatzakis A; Tassopoulos NC
J Hepatol; 1997 Jul; 27(1):36-41. PubMed ID: 9252071
[TBL] [Abstract][Full Text] [Related]
29. Is the detection of anti-hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor?
Pawlotsky JM; Remire J; Darthuy F; Intrator L; Udin L; Dhumeaux D; Duval J
J Med Virol; 1995 Jan; 45(1):68-70. PubMed ID: 7536232
[TBL] [Abstract][Full Text] [Related]
30. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
Ansari MA; Irshad M; Agarwal SK; Chosdol K
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
[TBL] [Abstract][Full Text] [Related]
31. Immunoglobulin G and M hepatitis C virus core antibody (JCC.2) response in chimpanzees infected experimentally with hepatitis C virus.
Shioda A; Moriyama M; Hayashi N; Sugitani M; Uchida T; Shikata T; Nishizono A; Abe K; Arakawa Y
Intervirology; 2000; 43(3):146-53. PubMed ID: 11044808
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of an enzyme immunoassay for hepatitis C virus antibody detection using a recombinant protein derived from the core region of hepatitis C virus genome.
Lopes EP; Granato CH; Lanzoni V; Granero L; Paranhos-Baccala G; Tomiyama H; Silva AE; Ferraz ML
Mem Inst Oswaldo Cruz; 2000; 95(5):717-20. PubMed ID: 10998223
[TBL] [Abstract][Full Text] [Related]
33. [Spontaneous HCV clearance: an association with gender, age, viral genotypes, infection transmission routes, and markers of HBV and HIV].
Fedorchenko SV; Martynovich TL; Liashok OV; Kariuk ZhA; Ianchenko VI
Ter Arkh; 2010; 82(3):52-6. PubMed ID: 20564924
[TBL] [Abstract][Full Text] [Related]
34. Antigenic relevance of F protein in chronic hepatitis C virus infection.
Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G
Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus (HCV)-related cryoglobulinemia: cryoglobulin type and anti-HCV profile.
Minopetrou M; Hadziyannis E; Deutsch M; Tampaki M; Georgiadou A; Dimopoulou E; Vassilopoulos D; Koskinas J
Clin Vaccine Immunol; 2013 May; 20(5):698-703. PubMed ID: 23467778
[TBL] [Abstract][Full Text] [Related]
36. [Dependence of IgG titers specific to various hepatitis C virus proteins on features of chronic infection course].
Poponin DM; Gorovits ÉS; Bondarenko AL
Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):57-61. PubMed ID: 22308730
[TBL] [Abstract][Full Text] [Related]
37. Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns.
Pawlotsky JM; Roudot-Thoraval F; Pellet C; Aumont P; Darthuy F; Remire J; Duval J; Dhumeaux D
J Clin Microbiol; 1995 May; 33(5):1357-9. PubMed ID: 7542272
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and clinical implications of the different genotypes of hepatitis C virus.
Bukh J; Miller RH
Hepatology; 1994 Jul; 20(1 Pt 1):256-9. PubMed ID: 7517384
[No Abstract] [Full Text] [Related]
39. Antigenic heterogeneity of the hepatitis C virus NS5A protein.
Dou XG; Talekar G; Chang J; Dai X; Li L; Bonafonte MT; Holloway B; Fields HA; Khudyakov YE
J Clin Microbiol; 2002 Jan; 40(1):61-7. PubMed ID: 11773093
[TBL] [Abstract][Full Text] [Related]
40. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
Pawlotsky JM; Darthuy F; Rémiré J; Pellet C; Udin L; Stuyver L; Roudot-Thoraval F; Duvoux C; Douvin C; Mallat A
J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
